| Identification | Back Directory | [Name]
N-DESMETHYL IMATINIB-D8 | [CAS]
1185103-28-9 | [Synonyms]
Norimatinib D8
N-DESMETHYL IMATINIB-D8
Imatinib EP Impurity C-D8
[2H8]-N-Desmethyl Imatinib
Imatinib desmethyl-d8 (as formate)
Imatinib metabolite N-Desmethyl imatinib D8
Imatinib EP Impurity C-d8 (N-Desmethyl Imatinib-d8)
N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]-4-[(2,2,3,3,5,5,6,6-octadeuteriopiperazin-1-yl)methyl]benzamide
N-Desmethyl Imatinib D8Q: What is
N-Desmethyl Imatinib D8 Q: What is the CAS Number of
N-Desmethyl Imatinib D8 Q: What is the storage condition of
N-Desmethyl Imatinib D8 | [Molecular Formula]
C28H29N7O | [MDL Number]
MFCD07369292 | [MOL File]
1185103-28-9.mol | [Molecular Weight]
479.576 |
| Chemical Properties | Back Directory | [Melting point ]
97-103°C | [storage temp. ]
-20°C Freezer | [solubility ]
Chloroform (Slightly), Dichloromethane (Slightly), Methanol (Slightly) | [form ]
Solid | [color ]
Pale Yellow to Yellow |
| Hazard Information | Back Directory | [Chemical Properties]
Yellow Solid | [Uses]
A deuterated metabolite of Gleevec, a tyrosine kinase inhibitor which is highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL). It is a COVID19-related research product. |
|
|